Small Molecules Targeting SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain-Reference-Cited by-同舟云学术

Small Molecules Targeting SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain

Published:2022-08-09 Issue:33 Volume:7 Page:28779-28789
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Rodríguez Yoel¹²^ORCID,Cardoze Scarlet Martínez¹,Obineche Onyinyechi W.¹,Melo Claudia³⁴^ORCID,Persaud Ashanna³,Fernández Romero José A.³⁵

Affiliation:

1. Department of Natural Sciences, Hostos Community College of The City University of New York, 500 Grand Concourse, Bronx, New York, New York 10451, United States

2. Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, New York 10029, United States

3. Department of Science, Borough of Manhattan Community College of The City University of New York, 199 Chambers St, New York, New York 10007, United States

4. Brooklyn College of The City University of New York, 2900 Bedford Avenue, New York, New York 11210, United States

5. Center for Biomedical Research, The Population Council, 1230 York Avenue, New York, New York 10065, United States

Funder

City University of New York

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c00844

Reference58 articles.

1. WHO. Coronavirus Disease 2019 (COVID-19)

2. Situation Report─Weekly epidemiological Update on COVID-19, 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.

3. Coronaviruses post-SARS: update on replication and pathogenesis

4. A Novel Coronavirus from Patients with Pneumonia in China, 2019

5. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants;Scientific Reports;2024-02-02

2. Development of SARS-CoV-2 entry antivirals;Cell Insight;2024-02

3. Exploring the Fatty Acid Binding Pocket in the SARS-CoV-2 Spike Protein – Confirmed and Potential Ligands;Journal of Chemical Information and Modeling;2023-11-22

4. Targeting the Receptor Binding Domain and Heparan Sulfate Binding for Antiviral Drug Development against SARS-CoV-2 Variants;2023-07-13

5. Investigating the binding affinity of andrographolide against human SARS-CoV-2 spike receptor-binding domain through docking and molecular dynamics simulations;Journal of Biomolecular Structure and Dynamics;2023-02-10